|
In
general, transducers take many forms and they dictate the
physicochemical parameter that will be measured. Thus, the transducer
may be optically-based, measuring such changes as optical absorption,
fluorescence, or refractive index. It may be mass-based, measuring the
change in mass that accompanies a biologically derived binding
reaction. Additionally, it may be thermally based (measuring the change
in enthalpy (heat) or impedance based (measuring the change in
electrical properties) that accompanies the analyte/bio-recognition
layer interaction.
Biosensors
generally do not permit the measurement of analytes that are not
measurable by some other means. As an example, the monoclonal
antibodies that comprise the biorecognition molecules of an
immuno-biotransducer could easily be used in a multi-well plate ELISA
(enzyme linked immunosorbent assay). In fact, many biosensors are
derived from previously performed laboratory-based bio assays.
Biosensors do however offer the convenience and facility of distributed
measurement, that is, the potential ability to take the assay to the
point of concern or care. Properly designed and manufactured, biosensor
devices may be conveniently mass-produced. The potential lower cost per
test is a compelling advantage. While detection limit and sensitivity
are often cited as important impediments to success, these only need be
appropriate to the test in question performed in the targeted market.
The
most successful biosensors are of course the range of highly
competitive blood glucose meters that may be purchased at the local
pharmacy. Each has its own proprietary twist on what is essentially an
enzyme electrode. In the Boringher-Roche Glucoscan, a freeze-dried
layer of the enzyme glucose oxidase is made to react with the glucose
found in the patient's whole blood. This enzyme transformation reaction
results in the production of hydrogen peroxide. The hydrogen peroxide
formed is oxidized directly or through redox mediation, at metallic
electrodes. The magnitude of the current is directly proportional to
the concentration of hydrogen peroxide produced, which is itself
proportional to the rate of conversion of the substrate glucose to
gluconolactone (gluconic acid).
Issues
in biosensor technology: (i) Time-dependant stability of the
bio-recognition layer. (ii) Reproducibility of the activity of the
bio-recognition layer. (iii) Vulnerability of the biotransducer to
foulants and interferences, (iv) Market sizes for biosensor-based
measurement devices. (v) Appropriateness of the
recognition/transduction device and form-factor of the integrated
system to the targeted market.
Future
directions in biosensor technology: (i)Increased range of
analytes addressed. (ii) Move towards completely integrated systems
possessing sample handling, microfluidics, detection and display
(possibly telemetry). (iii) Renewed emphasis on whole cell and tissue
biosensors. (iv) Use of embedded systems. (v) Telecommunications
capability.
Biosensors
have wide potential application in such diverse fields as personal
health monitoring, environmental screening and monitoring, bioprocess
monitoring, and within the food and beverage industry.
|